Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2020. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) | est un(e) (attribut) | Vaccine product containing only Streptococcus pneumoniae capsular polysaccharide antigen unconjugated (medicinal product) | true | Inferred relationship | Some | ||
| Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) | Count of active ingredient | 23 | false | Inferred relationship | Some | ||
| Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) | a pour principe actif (attribut) | Streptococcus pneumoniae capsular polysaccharide antigen unconjugated | true | Inferred relationship | Some | 1 | |
| Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) | est un(e) (attribut) | Pneumococcal polysaccharide vaccine (product) | false | Inferred relationship | Some | ||
| Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) | a pour principe actif (attribut) | Pneumococcal polysaccharide vaccine (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Pneumo 23 solution for injection Sanofi Pasteur SA (real clinical drug) | est un(e) (attribut) | True | Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) | Inferred relationship | Some | |
| Pneumovax 23 solution for injection Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | True | Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) | Inferred relationship | Some | |
| Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens only vaccine product | est un(e) (attribut) | False | Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
Historical name codes for vaccines reference set (foundation metadata concept)
FHIR